Code
|
36425
|
MA number
|
EU/1/06/337/013
|
Product Form:
|
plv sul 20x liek.+20x solv. (skl.liek.+napl.skl.striek.s 2 samost.ihlami)
|
MA Status:
|
E - Valid centralised marketing authorisation
|
Type of procedure:
|
EU
|
MAH, country:
|
Merck Sharp & Dohme B.V., Netherland
|
Therapeutic Class:
|
59 - IMMUNOPRAEPARATA
|
ATC:
|
J |
ANTIINFECTIVES FOR SYSTEMIC USE |
J07 |
VACCINES |
J07B |
VIRAL VACCINES |
J07BD |
Measles vaccines (old: Morbilli vaccines) |
J07BD52 |
Measles, co. w. mumps a. rubella, l. att. (old: Morbilli, co. w. parotit. a. rub., li. att.) |
|
Shelf life:
|
24 |
Container:
|
glass container
|
Route of admin.:
|
Subcutaneous and intramuscular use
|